|
[1]Graven RA, Totty N, Harnden P, et al.Lser capture microdissection and two-dimensional polyacrylamide gel electrophoresis:evaluation of tissue preparation and sample limitations[J].Am J Pathol, 2002, 161 (3) ∶815-822.
|
|
[2]Kumar S, Mohan A, Guleria R.Biomarkers in cancer screen in gre-search and detection:present and future:a review[J].Biomarkers, 2006, 11 (5) ∶385-405.
|
|
[3]Lawrie LC, Curran S.Laser capture microdissection and colorectal cancer proteomics[J].Methods Mol Biol, 2005, 29 (2) ∶245-253.
|
|
[4]Kange R, Selditz U, Granberg M, et al.Comparision of different IMAC techniques used for enrichment of phosphorylated peptides[J].J Biomol Tech, 2005, 16 (2) ∶91-103.
|
|
[5]Trakselis MA, Alley SC, Ishmael FT, et al.Identification and map-ping of protein-protein interations by a combination of cross-link-ing, eleavage, and proteomics[J].Bioconjug Chem, 2005, 16 (4) ∶741-750.
|
|
[6]Boguski MS, Mclntosh MW.Biomedical informatics for proteomics[J].Nature, 2003, 422 (6928) ∶233-237.
|
|
[7]Poon TC, Johnson P J.Proteomic analysis and its impact on the dis-covery of serological tumor markers[J].Clin Chim Acta, 2001, 313 (2) ∶231-239.
|
|
[8]Fung ET, Enderwick C.ProteinChip clinical proteomics:computa-tional challenges and solution[J].Biotechniques, 2002, (Suppl) ∶34-38, 40-41.
|
|
[9]Poon TC, Yip TT, Chan AT, et al.Comprehensive proteomic profi-ling identifies serum proteomic signatures for detection of hepatocellu-lar carcinoma and its subtypes[J].Clin Chem, 2003, 49 (5) ∶752-760.
|
|
[10]Steel LF, Shumpert D, Trotter M, et al.Astrategy for the compar-ative analysis of serum proteoms for the discovery of biomarkers for hepatocellular carcinoma[J].Proteomics, 2003, 3 (5) ∶601-609.
|
|
[11]Paradis V, Degos F, Dargere D, et al.Identification of a new marker of hepatocellular carcinoma by serum protei profiling of pa-tients with chronic liver diseases[J].Hepatology, 2005, 41 (1) ∶40-47.
|
|
[12]王征, 阮幼冰, 官阳.肝细胞癌患者血清蛋白质组成分的双向凝胶电泳-飞行时间质谱分析[J].中华病理学杂志, 2003, 32 (4) ∶333-336.
|
|
[13]Comunale MA, Lowman M, Long R E, et al.Proteomic analysis of serum associated fucosylated glycoproteins in the development of pri-mary hepatocellular carcinoma[J].J Proteome Res, 2006, 5 (2) ∶308-315.
|
|
[14]Ang I L, Poon TC, Lai P B, et al.Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma:a glycop-roteomic approach[J].J Proteome Res, 2006, 5 (10) ∶2691-2700.
|
|
[15]Li Y, Tang Z Y, Tian B, et al.Serum CYFRA21-1level reflects hepatocellular carcinoma metastasis:study in nude mice model and clinical patients[J].J Cancer Res Clin Oncol, 2006, 132 (8) ∶515-520.
|
|
[16]Ward DG, Cheng Y, Kontchou GN, et al.Changes in the serum proteome associated with the deveopment of hepatocellular carcinoma in hepatitis C-related cirrhosis[J].Br J Cancer, 2006, 94 (2) ∶287-292.
|
|
[17]Lee IN, Chen ch, Sheu JC, et al.Identification of complement C3a as acandidate biomarker in umanchronic hepatitis C and HCV-relat-ed hepatocellular carcinoma using a proteomics approach[J].Pro-teomics, 2006, 6 (9) ∶2865-2873.
|
PDF下载 ( 119 KB)
本文二维码
下载:
